CARsgen Therapeutics Holdings (HKSE:02171) EBIT per Share : HK$-1.54 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CARsgen Therapeutics Holdings EBIT per Share?

CARsgen Therapeutics Holdings's EBIT per Share for the six months ended in Dec. 2024 was HK$-0.86. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-1.54.

During the past 3 years, the average EBIT per Share Growth Rate was 15.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was -20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CARsgen Therapeutics Holdings's EBIT per Share or its related term are showing as below:

HKSE:02171' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -53.3 Med: -28.4 Max: 15.8
Current: 15.8

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of CARsgen Therapeutics Holdings was 15.80% per year. The lowest was -53.30% per year. And the median was -28.40% per year.

HKSE:02171's 3-Year EBIT Growth Rate is ranked better than
59.14% of 1236 companies
in the Biotechnology industry
Industry Median: 8.1 vs HKSE:02171: 15.80

CARsgen Therapeutics Holdings's EBIT for the six months ended in Dec. 2024 was HK$-473.12 Mil.

CARsgen Therapeutics Holdings EBIT per Share Historical Data

The historical data trend for CARsgen Therapeutics Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CARsgen Therapeutics Holdings EBIT per Share Chart

CARsgen Therapeutics Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-2.20

-14.96

-1.78

-1.46

-1.53

CARsgen Therapeutics Holdings Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBIT per Share	Get a 7-Day Free Trial						-1.03	-0.79	-0.67	-0.67	-0.86

CARsgen Therapeutics Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CARsgen Therapeutics Holdings's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-845.674	/	552.875
=	-1.53

CARsgen Therapeutics Holdings's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-473.116	/	548.720
=	-0.86

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-1.54

CARsgen Therapeutics Holdings (HKSE:02171) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CARsgen Therapeutics Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of CARsgen Therapeutics Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CARsgen Therapeutics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CARsgen Therapeutics Holdings Ltd (HKSE:02171) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 466 Yindu Road, Building 2, 1st Floor, Xuhui District, Shanghai, CHN

Website

https://www.carsgen.com

CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.

Executives

Bei Jing Shen Nong Tou Zi Guan Li Gu Fen You Xian Gong Si	2102 Investment manager
Candock Holdings Limited	2501 Other
Yi Jie Sheng Wu Ji Shu Kong Gu You Xian Gong Si	2501 Other
Yi De Kong Gu You Xian Gong Si	2501 Other
Quan Zhou Shi Ding Wo Chuang Feng Tou Zi Zhong Xin You Xian He Huo	2501 Other
Yang Xuehong	2501 Other
Wang Huamao	2401 A concert party to an agreement to buy shares
Li Zonghai	2401 A concert party to an agreement to buy shares
Guo Bingsen	2401 A concert party to an agreement to buy shares
Accure Biotech Limited	2501 Other
Cart Biotech Limited	2501 Other
Chen Haiou	2501 Other
Guo Xiaojing	2501 Other
He Xi Holdings Limited	2501 Other
Redelle Holding Limited	2501 Other

CARsgen Therapeutics Holdings Headlines

No Headlines